PARTNERS
In HEDIMED altogether 22 academic and industrial partners join their multidisciplinary and supplementary forces to identify exposomic determinants which are driving the epidemic of immune-mediated diseases.
This European-wide and cross-Atlantic network works in synergy to combine background knowledge, resources, technical competence, business and market experience, and clinical expertise.